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Abstract
Background: Sodium/iodide symporter (NIS) mediates the active transport and accumulation of iodide from the
blood into the thyroid gland. His-226 located in the extracellular region of NIS has been demonstrated to be
critical for iodide transport in our previous study. The conserved charged amino acid residues in the extracellular
region of NIS were therefore characterized in this study.
Methods: Fourteen charged residues (Arg-9, Glu-79, Arg-82, Lys-86, Asp-163, His-226, Arg-228, Asp-233, Asp-237,
Arg-239, Arg-241, Asp-311, Asp-322, and Asp-331) were replaced by alanine. Iodide uptake abilities of mutants were
evaluated by steady-state and kinetic analysis. The three-dimensional comparative protein structure of NIS was
further modeled using sodium/glucose transporter as the reference protein.
Results: All the NIS mutants were expressed normally in the cells and targeted correctly to the plasma membrane.
However, these mutants, except R9A, displayed severe defects on the iodide uptake. Further kinetic analysis
revealed that mutations at conserved positively charged amino acid residues in the extracellular region of NIS led
to decrease NIS-mediated iodide uptake activity by reducing the maximal rate of iodide transport, while mutations
at conserved negatively charged residues led to decrease iodide transport by increasing dissociation between NIS
mutants and iodide.
Conclusions: This is the first report characterizing thoroughly the functional significance of conserved charged
amino acid residues in the extracellular region of NIS. Our data suggested that conserved charged amino acid
residues, except Arg-9, in the extracellular region of NIS were critical for iodide transport.
Background
Sodium/iodide symporter (NIS) is a transmembrane glyco-
protein that is functionally expressed in thyroids, salivary
glands, gastric mucosa, and lactating mammary glands [1].
NIS mediates the active transport of iodide into the folli-
cular thyroid cells and, in turn, concentrates iodide in the
thyroid glands. The ability of cancerous thyroid cells to
actively transport iodide via NIS has provided a unique
and effective delivery system for the detection and destruc-
tion of these cells with radioiodide [2].
NIS is a member of solute-sodium symporters. Solute-
sodium symporters are a large family of proteins that co-
transport sodium ions with sugars, amino acids, vitamins,
or iodide [3,4]. So far, more than 250 members of solute-
sodium symporters family have been identified, and sev-
eral members, including NIS, human sodium/glucose
transporter (hSGLT), Vibrio parahaemolyticus SGLT
(vSGLT) and Escherichia coli (E. coli) proline symporter,
have been well characterized [2-4]. NIS as well as other
members transport sodium and solute via an alternating
access mechanism with tight coupling between sodium
and solute transport [5-7]. However, the absence of struc-
tural/functional data of NIS may be difficult to explain this
hypothesis.
NIS mutations detected in patients with congenital
iodide transport defect (ITD) have provided the signifi-
cant structural/functional information about NIS. Twelve
ITD-causing NIS mutations, which are situated in the
transmembrane or intracellular segments of NIS, have
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G395R, T354P, frame-shift 515X, Y531X, G543E,
ΔM143-Q323, and ΔA439-P443 [2,8]. Mutations at the
highly conserved serine and threonine residues in the
transmembrane segment IX have shown that Thr-351,
Ser-353, Thr-354, Ser-356, and Thr-357 play a key role in
sodium/iodide co-transport [9]. Phosphorylation sites
(Ser-43, Thr-49, Ser-227, Thr-577, and Ser-581) of NIS
have been identified to be important for NIS protein sta-
bility and function [10]. In addition, His-226 located in
the extracellular region of NIS is critical for iodide trans-
port in our previous study [11]. Moreover, deletion in the
region spanning residues 233-280 of NIS loses the iodide
uptake activity [12]. In this study, we elucidated the
importance of 14 conserved charged amino acid residues,
which were located in the extracellular region of NIS, by
site-directed mutagenesis and kinetic analysis. Our find-
ings indicated that all mutants, except R9A, displayed
severe defects on the iodide uptake. Moreover, mutations
at positively charged amino acid residues led to the
decrease in Vmax, while mutations at negatively charged
residues resulted in the increase in Km. Our data sug-
gested that conserved charged amino acid residues,
except Arg-9, in the extracellular region of NIS were cri-
tical for iodide transport.
Methods
Cloning and site-directed mutagenesis
Human NIS cDNA was cloned as described previously
[11]. Briefly, two overlapping cDNA fragments represent-
ing either the 5’-half or the 3’-half of the complete NIS
coding region were amplified and inserted into pBlue-
script®II KS (-) vector to create pBKS-NIS-5’ and pBKS-
NIS-3’ plasmids, respectively. A full-length NIS clone was
then constructed by in-frame fusion of both halves using
au n i q u eBgl II site in the overlap of the fragments. Site-
directed mutagenesis was performed as described pre-
viously [13]. Briefly, uracil-containing single-stranded
DNA (ssDNA) was prepared by transforming pBKS-NIS-
5’ into E. coli CJ236 strain. Uracil-containing ssDNA was
annealed with 5’-kinase primer, the second-stranded
DNA was synthesized, and the double-stranded DNA
was then transformed into E. coli NM522 strain to allow
the mutated strand to be amplified. The full-length NIS
mutant clones were subcloned into pcDNA3.1 expression
vector (Invitrogen, SanDiego, CA) to create pcDNA3.1-
NIS plasmid DNA. The primers for the construction of
NIS mutants are shown in Additional File 1; Table S1.
All the mutants created in this study were confirmed by
sequencing (Additional File 1; Table S2).
Cell culture and transient transfection
Human hepatoblastoma HepG2 cell line was maintained
in Dulbecco’s modified Eagle’s medium (DMEM) (Life
Technologies, Gaithersburg, MD) supplemented with
10% fetal bovine serum (HyClone, Logan. UT). HepG2
cells were transiently transfected with pcDNA3.1-NIS
wild-type, pcDNA3.1-NIS mutants, pcDNA3.1, or
pcDNA3.1/lacZ by SuperFect® transfection reagent (Qia-
gen Inc., Valencia, CA). Transfected cells were then
kept in a humidified incubator at 37°C with 5% CO2
for 24 h.
Total RNA extraction and reverse transcription-
polymerase chain reaction (RT-PCR)
RNA extraction and RT were performed as described pre-
viously [11]. RNA integrity was electrophoretically verified
by both the ethidium bromide staining and the absorption
ratio (OD260/OD280 > 1.95). RT mixtures were subjected
to PCR to measure the mRNAs of NIS and b-actin. PCR
amplification was performed with Taq polymerase (Pro-
mega, Madison, WI) for 20 cycles at 94°C for 45 s, 50°C for
45 s, and 72°C for 1 min. PCR primers for NIS were as
follows: sense, 5’-CTCCTCCCTGCTAACGACTC-3’; anti-
sense, 5’-CGACCACCATCATGTCCAAC-3’;P C Rp r i m e r s
for b-actin were as follows: sense, 5’-TGACGGGGTCACC
CACACTGTGCCCATCTA-3’;a n t i s e n s e ,5 ’-CTAGAAGC
ATTGCGGTGGACGATGGAGGG-3’.
Western blot analysis
The cellular proteins (10 μg) were separated by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis, and the protein bands were then transferred elec-
trophoretically to nitrocellulose membranes. Membranes
were blocked in blocking buffer (20 mM Tris-HCl, pH
7.6, 140 mM NaCl, 0.1% Tween 20, and 5% skim milk)
and probed with mouse monoclonal antibody against
NIS (Lab Vision, Fremont, CA) or rabbit polyclonal
antibody against b-actin (Santa Cruz, Santa Cruz, CA).
The bound antibody was detected with peroxidase-con-
jugated anti-mouse or anti-rabbit antibody followed by
enhanced chemiluminescence system (Amersham, Chal-
font St. Giles, Buckinghamshire, UK) and exposed by
autoradiography.
Immunofluorescent staining
HepG2 cells were seeded in 24-well plates containing
sterilized coverslips, incubated at 37°C for 2 days, and
transiently transfected with DNAs. One day later, cells
were washed twice with phosphate-buffered saline (PBS)
(137 mM NaCl, 1.4 mM KH2PO4,4 . 3m MN a 2HPO4,
2.7 mM KCl, pH 7.2), fixed with 3.7% PBS-buffered for-
maldehyde for 30 min at room temperature, and washed
three times with PBS. Coverslips were then incubated
with mouse anti-NIS monoclonal antibody overnight at
4°C, washed three times with PBS, and incubated with
fluorescein-conjugated goat anti-mouse IgG antibody
(Jackson ImmunoResearch, West Grove, PA) for 2 h at
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confocal microscope (Leica, Germany), with an excita-
tion wavelength of 488 nm. Anti-NIS monoclonal anti-
body was against residues 625 to 643 mapping to the
carboxyl terminus of human NIS.
Iodide uptake and reporter assays
For steady-state analysis, cells were incubated for 1 h
with 10.2 μCi/ml carrier-free Na
125Ii n1m lD M E Ma t
37°C. For the inhibition of NIS-mediated uptake,
NaClO4, in a final concentration of 30 μM, was included
in parallel incubations. After a 1-h incubation, medium
was completely removed and washed twice with 2 ml
ice-cold PBS. After washing, the cells were lysed with
350 μl Triton lysis buffer (50 mM Tris-HCl, pH 7.8, 1%
Triton X-100, 1 mM dithiothreitol). Radioactivities of
l y s a t e sw e r ed e t e r m i n e db yaC o b r aI Ia u t o - g a m m a
counter (Packard BioScience, Dreieich, Germany). b-
Galactosidase activities of cell lysates were analyzed by
mixing cell lysates with O-nitrophenyl-b-D-galactopyra-
noside. After a 30-min incubation at 37°C, the absor-
bance values of the mixtures were measured at 420 nm.
For kinetic analysis, cells were incubated for 4 min with
6.25, 12.5, 25, 50, and 100 μM NaI, and uptake reactions
were determined as described aforementioned. Data were
processed using the equation: v =( Vmax × [I])/(Km+
[I]) + 0.0156 × [I] + 2.4588. The terms 0.0156 × [I] +
2.4588 correspond to background adjusted by least
squares to the data obtained with non-transfected cells.
Molecular modeling
The three-dimensional comparative protein structure of
NIS was modeled using vSGLT (PDB ID: 3dh4) as the
reference protein. Protein structure was built using
SWISS-MODEL workspace [14]. ‘Frankenstein’sm o n -
ster’ approach was applied to refinement of the NIS
structure [15].
Statistical analysis
Data were presented as mean ± standard error. Stu-
dent’s t test was used for comparisons between groups.
A p value < 0.05 was considered to be statistically
significant.
Results
Characterization of expression and plasma membrane
targeting of wild-type and mutated NIS proteins in
HepG2 cells
The current NIS secondary structure model depicts NIS
as a protein with 13 transmembrane segments [16].
Multiple alignments of NIS amino acid sequences from
human, pig, mouse, and rat showed that 14 charged
residues (Arg-9, Glu-79, Arg-82, Lys-86, Asp-163, His-
226, Arg-228, Asp-233, Asp-237, Arg-239, Arg-241,
Asp-311, Asp-322, and Asp-331) were highly conserved
among NIS analogs (Additional File 1; Fig. S1). Addi-
tionally, all of these charged residues were located on
the extracellular region of NIS (Figure 1). Therefore, 14
conserved charged residues were then replaced with
noncharged amino acid, alanine, by site-directed
mutagenesis.
To verify the expression levels and plasma membrane
targeting of NIS mutants, HepG2 cells were transiently
transfected with wild-type or mutated NIS DNAs.
Twenty-four hours later, the mRNA level, protein level,
and plasma membrane targeting of NIS were evaluated
by RT-PCR, Western blot, and Immunofluorescent stain-
ing, respectively. As shown in Figure 2A, no apparent
difference of mRNA level was found in HepG2 cell
expressing either wild type or mutants. By using mouse
monoclonal antibody against the C-terminus of NIS,
mutated NIS-expressing cells displayed the similar
protein amount and plasma membrane-associated immu-
nofluorescence staining pattern with wild-type NIS-
expressing cells (Figures 2B and 2C). These findings
indicated that NIS mutants were expressed normally in
the cells and targeted correctly to the plasma membrane.
Iodide uptake activities of NIS mutants
HepG2 cells were transiently transfected with pcDNA3.1/
lacZ and pcDNA3.1, wild-type, or mutated NIS DNAs.
Twenty-four hours later, the iodide uptake activity was
analyzed by steady-state iodide uptake assay and the
transfection efficiency was monitored by b-galactosidase
assay. As shown in Figure 3, wild-type NIS-expressing
cells exhibited a significant highly iodide uptake activity.
Perchlorate treatment led to a markedly decrease in
iodide uptake, suggesting the specificity of iodide uptake
assay. Mutation at Arg-9 displayed no defect on the
iodide uptake activity, suggesting that Arg-9 was not
involved in the iodide transport of NIS. However, repla-
cement of other charged amino acid residues with ala-
nine resulted in a large decrease in iodide uptake activity.
b-Galactosidase activities were consistent in wild-type
and mutated NIS-expressing cells, indicating that the
dramatic reduced iodide uptake activities resulted from
the amino acid substitution instead of transfection varia-
tion. These findings suggested that conserved charged
amino acid residues, except Arg-9, in the extracellular
region of NIS were critical for iodide transport.
Kinetics analysis of NIS mutants
We further analyzed the kinetic properties of iodide
uptake in HepG2 cells expressing wild-type or mutated
NIS. Initial rates were assessed by measuring iodide
accumulation at 4-min time points over a range of 6.25,
12.5, 25, 50, and 100 μM NaI (Figure 4). Typical Michae-
lis-Menten kinetic was used to determine the Vmax and
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monitored by b-galactosidase assay. b-Galactosidase
activities were consistent in wild-type and mutated NIS-
expressing cells, indicating that the transfection efficien-
cies were consistent in wild-type and mutants (Additional
File 1; Fig. S2).A comparison of kinetic parameters for
wild type and mutants is shown on Table 1. Because R9A
displayed no defect on the iodide uptake activity, we did
not elucidate the role of Arg-9 further. Replacement of
positively charged residues (Arg-82, Lys-86, His-226,
Arg-228. Arg-239, and Arg-241) by alanine resulted in a
dramatic reduction in Vmax. However, mutations at
negatively charged residues, except Asp-331, led to a
slight change in Vmax. These findings indicated that
Asp-331- and basic residues-altered mutants displayed a
lower turnover rate. Replacement of Arg-239, Asp-163,
Asp-233, Asp-237, and Asp-322 with alanine resulted in
a significant increase in Km. However, mutation at Arg-
82 showed a markedly decrease in Km. Replacement of
other residues with alanine led to slight alternation in
Km. These findings indicated that the dissociation of the
Michaelis complex between mutants (R239A, D163A,
D233A, D237A, and D322A) and iodide was larger than
that of wild-type NIS, while the dissociation between
R82A mutant and iodide was smaller than that of wild-
type NIS.
Discussion
Mutations at the amino acid residues in the transmem-
brane or intracellular segments of NIS have identified
the roles of these residues on the iodide transport. For
examples, mutations at Val-59 in the transmembrane
segment II and Gln-267 in the intracellular loop have
led to severe defects on the iodide uptake [17,18]. Muta-
tions at the highly conserved serine and threonine resi-
dues in the transmembrane segment IX and intracellular
loops have revealed that these residues play key roles in
the sodium/iodide co-transport [9,10]. In addition to the
amino acid residues in the transmembrane or intracellu-
lar segments, some studies have shown that extracellular
loops play essential roles for the ion transport in other
transporters, such as apical sodium-dependent bile acid
transporter, serotonin transporter, sodium pump alpha
subunit, and chloride/bicarbonate anion exchanger
[19-23]. Therefore, herein we analyzed the critical roles
of amino acid residues in the extracellular segments of
N I S ,a n do u rf i n d i n g si n d i c a t e dt h a tt h e s er e s i d u e s
affected the iodide transport via various mechanisms.
E79
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R228
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D311 
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D233
D237
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Figure 1 Schematic representation of NIS secondary structure model. The schematic diagram shows the predicted secondary structure of
NIS. The commonly accepted topological model of NIS shows 13 transmembrane helices with N terminus located extracellularly and C terminus
located intracellularly. Transmembrane segments are represented by cylinders. Positions of 14 amino acid residues mutated in this study are
indicated by arrows.
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have been shown to be involved in ion transport. For
examples, charged residues of kidney electrogenic
sodium-bicarbonate cotransporter are involved in ion
recognition in putative outward-facing and inward-
facing conformation [24]. Histidine residues of E. coli
Na
+/H
+ exchanger NhaA and Arabidopsis cation/H
+
exchanger are important for ion transport [22,25].
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Figure 2 Expression and plasma membrane targeting of NIS mutants. (A) RT-PCR. HepG2 cells were cultured in 25-cm
2 flasks and
transfected with wild-type (wt), R9A, E79A, R82A, K86A, D163A, H226A, R228A, D233A, D237A, R239A, R241A, D311A, D322A, or D331A plasmid
DNAs. Total RNAs were extracted and 1 μg of total RNA was reverse transcribed. The resulting cDNAs were then amplified by PCR. PCR products
were resolved in 1% agarose gels and visualized with ethidium bromide. (B) Western blot. HepG2 cells were cultured in 25-cm
2 flasks and
transfected with wt or mutated NIS DNAs. The NIS and b-actin proteins in the cellular lysates were detected by Western blot. (C)
Immunofluorescent staining. HepG2 cells were cultured on glass coverslips and transfected without (blank) or with pcDNA3.1 (mock), wt, or
mutated NIS DNAs for 2 days. Cells were then treated with anti-NIS antibody, stained with fluorescence-conjugated secondary antibody, and
evaluated under a confocal microscope. Magnification, 400×. Similar results were obtained in three independent experiments.
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Figure 3 Iodide uptake activities of NIS mutants. HepG2 cells were transfected with pcDNA3.1/lacZ and pcDNA3.1 (mock), wild-type (wt),
R9A, E79A, R82A, K86A, D163A, H226A, R228A, D233A, D237A, R239A, R241A, D311A, D322A, or D331A DNAs. Twenty-four hours later, iodide
uptake abilities and b-galactosidase activities were determined as described in Materials and Methods. Iodide uptake abilities are expressed as
relative iodide uptake, which is present as the comparison with the radioactivity relative to wt. b-Galactosidase activities are expressed as OD420.
Values are mean ± standard error of triplicate assays.
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+/bicarboxylate co-
transporter leads to a decrease in succinate transport
[26]. Histidine residues of human proton-coupled folate
transporter SLC46A1 play an important role in
SLC46A1 protonation [27]. Moreover, His-226 is critical
for the iodide uptake activity of NIS [13]. Furthermore,
arginine residues of organic anion transporter 1 influ-
ence the binding of glutarate and interact with chloride
[28]. Arg-211 residue of rabb i tp r o t o n - c o u p l e dp e p t i d e
transporter PepT1 plays an intriguing role in the function
of PepT1 [29]. In this study, we replaced the conserved
charged amino acid residues with alanine and found that,
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Figure 4 Kinetic analysis of NIS mutants. HepG2 cells were transfected with pcDNA3.1 (mock), wild-type (wt), or mutated NIS DNAs. After 24
h, initial rates (4 min time points) of iodide uptake were determined at the indicated concentrations of iodide. Calculated curves were
generated using the equation v =( Vmax × [I])/(Km + [I]) + 0.0156 × [I] + 2.4588. The terms 0.0156 × [I] + 2.4588 correspond to background
adjusted by least squares to the data obtained with non-transfected cells. Values are mean ± standard error of triplicate assays.
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iodide transport. Kinetic analysis revealed that all
mutants mutated at the positively charged amino acids
showed a dramatic reduction in Vmax, while most of the
mutants mutated at the negatively charged residues dis-
played an increase in Km. These findings suggested that
mutations at conserved basic amino acid residues in the
extracellular segments of NIS led to decrease NIS-
mediated iodide uptake activity by reducing the maximal
rate of iodide transport, while mutations at the conserved
acidic amino acid residues led to decrease iodide trans-
port by increasing dissociation between mutants and
iodide. Additionally, mutants in this study displayed
reduced iodide uptake activities, suggesting that muta-
tions at the extracellular region may lead to the lethal
effect in vivo.T h i ss p e c u l a t i o nm a ye x p l a i nw h yN I S
mutations in patients with ITD are all located in the
transmembrane and intracellular segments, but not in
the extracellular domain.
To explain why these conserved amino acid residues
affected the iodide transport, we built the three-dimen-
sional structure of NIS using vSGLT as a template pro-
tein. NIS has a sequence identity of 21.8% (37.6%
similarity) to vSGLT (Additional File 1; Fig. S3). NIS
and vSGLT are the members of solute-sodium sympor-
ters that co-transport sodium ions with sugars or iodide
ions. Moreover, both share an alternating-access
mechanism with tight coupling between sodium ion and
solute transport [30]. The recognized homology sug-
gested that using vSGLT as the template for the model-
ing of NIS is reasonable. The three-dimensional
structure of NIS (residues 50-443) is shown on Figure 5.
The proposed structure of NIS contained transmem-
brane helices in an inward-facing conformation. Amino
acid residues mutated in this study were located on the
extracellular segments, as expected. Interestingly, posi-
tively charged amino acid residues were situated on one
side. Structure viewed from the extracellular side dis-
played the core structure of NIS (Figure 5B). Glu-79,
Arg-82, Lys-86, His-226, Arg-228, and Asp-237 were
localized around the core. Glu-79, Arg-82, and Asp-237
were localized on one side of the core. Mutations at
these residues affected the Km values, suggesting that
these amino acid residues might influence the binding
of iodide ions. Lys-86, His-226, and Arg-228 were situ-
ated on the other side of the core. Mutations at these
residues altered the Vmax values, suggesting that these
residues might be involved in the transport of iodide
ions. Asp-233, Arg-239, and Arg-241 were also situated
around the core. However, the side chains of these resi-
dues were exposed to the surface. Mutations at Asp-233
and Arg-239 affected the Km values, suggesting that
both residues might influence the entry or binding of
the iodide ions. Asp-163, Asp-311, and Asp-331 were
situated far from the core, and the side chain of Asp-
163 was extruded into the surface. Because mutation at
Asp-163 altered the Km dramatically, Asp-163 might
affect the entry or binding of iodide ions. It is interest-
ing to find that residues (Glu-79, Arg-82, Asp-233, Asp-
237, Arg-239, and Arg-241) involved in the entry or
binding of iodide ions were situated on one side of the
core, while residues (Lys-86, His-226, and Arg-228)
involved in the iodide transport were localized on the
other side (Figure 5C). These findings suggested that
iodide ions might be attracted by residues on one side
of the core and then transported by residues on the
other side. Previous study has shown that five hydroxyl-
containing residues (Thr-351, Ser-353, Thr-354, Ser-356,
and Thr-357) and Asn-360 play a key role in sodium/
iodide co-transport [9]. These residues are situated
along one face of transmembrane segment IX and
located along the cavity might explain why these resi-
dues are critical for iodide transport.
Conclusions
In conclusion, we have characterized the roles of 14 con-
served charged amino acid residues located in the extra-
cellular regions of NIS. We have shown that mutation at
these charged amino acid residues, except Arg-9, led to
the severe defects on the iodide uptake. Moreover, kinetic
analysis has shown that mutations at positively charged
residues led to decrease iodide uptake activity by redu-
cing the maximal rate of iodide transport, while muta-
tions at negatively charged residues led to decrease
iodide transport by increasing dissociation between
mutants and iodide. This is the first report characterizing
thoroughly the functional significance of conserved
charged amino acid residues in the extracellular region of
Table 1 Kinetic analysis of human NIS mutants
NIS mutants Vmax
a Km
a
Wild type 7.94 ± 0.2 81.35 ± 8.89
R82A 2.46 ± 0.31*** 32.87 ± 5.58**
K86A 5.49 ± 0.61** 68.97 ± 14.08
H226A 2.02 ± 0.48*** 71.37 ± 12.43
R228A 4.67 ± 0.45*** 91.8 ± 7.2
R239A 2.42 ± 0.45*** 171.23 ± 36.12**
R241A 2.15 ± 0.14*** 67.64 ± 14.69
E79A 8.55 ± 0.46 110.42 ± 39.87
D163A 9.46 ± 3.1 166.51 ± 37.9*
D233A 8.37 ± 1.6 207.49 ± 72.65*
D237A 7.93 ± 0.52 133.46 ± 43.93*
D311A 6.37 ± 0.69 59.89 ± 16.84
D322A 9.45 ± 1.11 496.6 ± 67.35***
D331A 3.98 ± 0.72*** 91.27 ± 15.32
a Values are mean ± standard error of triplicate assays.
*p < 0.05, **p < 0.01, ***p < 0.001, compared with wild type.
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the complete mechanism of iodide transport of NIS.
Additional material
Additional file 1: Supplementary Information. Table S1: DNA
oligonucleotides for the construction of human NIS mutants. Table S2:
Sequencing analysis of NIS mutants. Figure S1: Multiple alignments of NIS
homologs. Amino acid sequences of NIS from mouse, rat, and pig were
aligned with those of human by ClustalW http://www.ebi.ac.uk. Residues
that are identical in all NIS homologs are indicated by asterisks. Residues
that are located on the extracellular region are highlighted in grey.
Amino acid residues mutated in this study are indicated in red. Figure S2:
b-Galactosidase activities of NIS mutants. HepG2 cells were transfected
with pcDNA3.1 (mock), wild-type (wt), or mutated NIS DNAs. After 24 h,
b-galactosidase activities were determined as described in Materials and
Methods. b-Galactosidase activities are expressed as OD420. Values are
mean ± standard error of triplicate assays. Figure S3: Amino acid
sequence alignment and secondary structure of human NIS. Amino acid
sequences of NIS were aligned with those of vSGLT by ClustalW.
Residues that are identical in both proteins are indicated by asterisks.
Amino acid residues mutated in this study are highlighted in red. The a-
helices of vSGLT are indicated by arrows. The dashed lines represent
amino acid segments that were not visualized in the crystal structure of
vSGLT.
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